Trial intelligence / Profile preview

Pancreatic Enzymes in Short Bowel Syndrome

NCT03097029Phase 2Completed

Sponsor
Children's Hospital of Philadelphia
Start
Mar 2017
Primary completion
Feb 2019
Modality
Replacement Enzymes
Countries
1
01

Overview

A Phase 2 trial of pancreatin in short bowel syndrome (SBS), sponsored by Children's Hospital of Philadelphia. Started Mar 2017; status: completed.

02

Drugs

pancreatin
03

Conditions

short bowel syndrome (SBS)

Beyond the preview

Go deeper on NCT03097029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03097029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call